Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of SHILPA MEDICARE. For more details, see the SHILPA MEDICARE quarterly results and SHILPA MEDICARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -3.3 |
No. of shares | m | 86.80 |
1 Week | % | 3.4 |
1 Month | % | 18.1 |
1 Year | % | 107.8 |
52 week H/L | Rs | 544.2/228.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SHILPA MEDICARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 547 | 539 | 692 | 671 | 503 | |
Low | Rs | 335 | 191 | 251 | 340 | 222 | |
Sales per share (Unadj.) | Rs | 90.0 | 111.4 | 110.5 | 132.0 | 121.0 | |
Earnings per share (Unadj.) | Rs | 13.4 | 19.0 | 17.9 | 7.0 | -3.6 | |
Diluted earnings per share | Rs | 12.6 | 17.8 | 16.8 | 7.0 | -3.6 | |
Cash flow per share (Unadj.) | Rs | 18.6 | 24.3 | 24.6 | 16.2 | 7.4 | |
Dividends per share (Unadj.) | Rs | 1.00 | 1.10 | 1.10 | 1.10 | 0 | |
Adj. dividends per share | Rs | 0.94 | 1.03 | 1.03 | 1.10 | 0.00 | |
Avg Dividend yield | % | 0.2 | 0.3 | 0.2 | 0.2 | 0 | |
Book value per share (Unadj.) | Rs | 146.9 | 163.1 | 181.4 | 209.9 | 205.4 | |
Adj. book value per share | Rs | 138.0 | 153.1 | 170.3 | 209.9 | 205.4 | |
Shares outstanding (eoy) | m | 81.53 | 81.53 | 81.53 | 86.80 | 86.80 | |
Price / Sales ratio | x | 4.9 | 3.3 | 4.3 | 3.8 | 3.0 | |
Avg P/E ratio | x | 32.8 | 19.2 | 26.3 | 72.4 | -101.8 | |
P/CF ratio (eoy) | x | 23.7 | 15.0 | 19.2 | 31.2 | 48.8 | |
Price / Book Value ratio | x | 3.0 | 2.2 | 2.6 | 2.4 | 1.8 | |
Dividend payout | % | 7.4 | 5.8 | 6.1 | 15.8 | 0 | |
Avg Mkt Cap | Rs m | 35,951 | 29,739 | 38,458 | 43,854 | 31,485 | |
Total wages/salary | Rs m | 1,764 | 1,966 | 2,353 | 2,645 | 2,873 |
SHILPA MEDICARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,334 | 9,079 | 9,011 | 11,455 | 10,501 | |
Other income | Rs m | 156 | 222 | 401 | 209 | 314 | |
Total revenues | Rs m | 7,489 | 9,301 | 9,412 | 11,664 | 10,815 | |
Gross profit | Rs m | 1,659 | 2,142 | 2,308 | 2,023 | 845 | |
Depreciation | Rs m | 421 | 438 | 540 | 798 | 955 | |
Interest | Rs m | 37 | 46 | 219 | 412 | 587 | |
Profit before tax | Rs m | 1,357 | 1,881 | 1,951 | 1,023 | -383 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 262 | 335 | 488 | 417 | -74 | |
Profit after tax | Rs m | 1,095 | 1,546 | 1,462 | 606 | -309 | |
Gross profit margin | % | 22.6 | 23.6 | 25.6 | 17.7 | 8.0 | |
Effective tax rate | % | 19.3 | 17.8 | 25.0 | 40.8 | 19.2 | |
Net profit margin | % | 14.9 | 17.0 | 16.2 | 5.3 | -2.9 |
SHILPA MEDICARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,451 | 6,239 | 8,625 | 8,872 | 7,680 | |
Current liabilities | Rs m | 2,534 | 4,108 | 5,875 | 6,115 | 7,829 | |
Net working cap to sales | % | 39.8 | 23.5 | 30.5 | 24.1 | -1.4 | |
Current ratio | x | 2.2 | 1.5 | 1.5 | 1.5 | 1.0 | |
Inventory Days | Days | 39 | 20 | 32 | 45 | 38 | |
Debtors Days | Days | 1,014 | 992 | 946 | 1,231 | 1,127 | |
Net fixed assets | Rs m | 10,650 | 13,654 | 17,296 | 19,883 | 21,344 | |
Share capital | Rs m | 82 | 82 | 82 | 87 | 87 | |
"Free" reserves | Rs m | 11,894 | 13,212 | 14,705 | 18,135 | 17,746 | |
Net worth | Rs m | 11,976 | 13,294 | 14,787 | 18,222 | 17,833 | |
Long term debt | Rs m | 811 | 1,650 | 4,742 | 3,536 | 2,888 | |
Total assets | Rs m | 16,100 | 19,892 | 26,324 | 28,755 | 29,024 | |
Interest coverage | x | 37.9 | 42.3 | 9.9 | 3.5 | 0.3 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | |
Return on assets | % | 7.0 | 8.0 | 6.4 | 3.5 | 1.0 | |
Return on equity | % | 9.1 | 11.6 | 9.9 | 3.3 | -1.7 | |
Return on capital | % | 10.9 | 12.9 | 11.1 | 6.6 | 1.0 | |
Exports to sales | % | 54.2 | 57.2 | 56.1 | 56.7 | 26.4 | |
Imports to sales | % | 22.3 | 20.9 | 24.8 | 19.0 | 4.7 | |
Exports (fob) | Rs m | 3,976 | 5,191 | 5,058 | 6,493 | 2,770 | |
Imports (cif) | Rs m | 1,633 | 1,900 | 2,231 | 2,176 | 494 | |
Fx inflow | Rs m | 3,987 | 5,206 | 5,078 | 6,514 | 2,841 | |
Fx outflow | Rs m | 1,768 | 2,138 | 3,322 | 2,814 | 1,399 | |
Net fx | Rs m | 2,219 | 3,069 | 1,756 | 3,700 | 1,443 |
SHILPA MEDICARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,468 | 1,244 | 469 | 1,051 | 2,262 | |
From Investments | Rs m | -1,962 | -2,895 | -4,043 | -2,855 | -2,785 | |
From Financial Activity | Rs m | 101 | 1,755 | 4,364 | 829 | 458 | |
Net Cashflow | Rs m | -395 | 102 | 790 | -975 | -65 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Omprakash Inani | COMP SEC: Ritu Tiwary | YEAR OF INC: 1987 | BSE CODE: 530549 | FV (Rs): 1 | DIV YIELD (%): - |
Read: SHILPA MEDICARE 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SHILPA MEDICARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.